{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:00:30Z","timestamp":1787310030211,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jad.2020.03.014","type":"journal-article","created":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T23:56:37Z","timestamp":1583711797000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"269","author":[{"given":"Babette","family":"Bais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina M.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmar H.","family":"Bijma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witte J.G.","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis L.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie I.","family":"Luik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijke P.","family":"Lambregtse-van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid M.","family":"Kamperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.03.014_bib0001","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00737-016-0637-1","article-title":"Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration\u2019s Mini-Sentinel program","volume":"19","author":"Andrade","year":"2016","journal-title":". Arch. Womens Ment. Health"},{"key":"10.1016\/j.jad.2020.03.014_bib0002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-199448010-00004","article-title":"Guidelines for the rational use of benzodiazepines. When and what to use.","volume":"48","author":"Ashton","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.jad.2020.03.014_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/945621","article-title":"Maternal characteristics of women exposed to hypnotic benzodiazepine receptor agonist during pregnancy","volume":"2014","author":"Askaa","year":"2014","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.jad.2020.03.014_bib0004","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.ajog.2007.10.780","article-title":"Universal screening for substance abuse at the time of parturition","volume":"198","author":"Azadi","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"(8) Suppl","key":"10.1016\/j.jad.2020.03.014_bib0005","first-page":"5","article-title":"A cross-national comparison of anti-anxiety\/sedative drug use","volume":"4","author":"Balter","year":"1984","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2020.03.014_bib0006","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/clpt.1994.57","article-title":"Objectively measured perinatal exposure to meperidine and benzodiazepines in Finland","volume":"55","author":"Bardy","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2020.03.014_bib0007","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.pra.0000438183.74359.46","article-title":"Perinatal antidepressant use: understanding women\u2019s preferences and concerns","volume":"19","author":"Battle","year":"2013","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jad.2020.03.014_bib0008","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0140-6736(92)92232-5","article-title":"Effects of exposure to benzodiazepine during fetal life","volume":"340","author":"Bergman","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2020.03.014_bib0009","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12884-019-2285-8","article-title":"Use of antidepressants and anxiolytics in early pregnancy and the risk of preeclampsia and gestational hypertension: a prospective study","volume":"19","author":"Bernard","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jad.2020.03.014_bib0010","first-page":"39","article-title":"A major change of prescribing pattern in absence of adequate evidence: benzodiazepines versus newer antidepressants in anxiety disorders","volume":"41","author":"Berney","year":"2008","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2020.03.014_bib0011","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/CLEP.S17747","article-title":"Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark","volume":"3","author":"Bjorn","year":"2011","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.jad.2020.03.014_bib0012","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007696","article-title":"Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs","author":"Blotiere","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2020.03.014_bib0013","first-page":"149","article-title":"The prevalence of chemical substance and alcohol abuse in an obstetric population in Dublin","volume":"90","author":"Bosio","year":"1997","journal-title":"Ir. Med. J."},{"key":"10.1016\/j.jad.2020.03.014_bib0014","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011"},{"key":"10.1016\/j.jad.2020.03.014_bib0015","first-page":"1001","article-title":"ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation","volume":"111","author":"Bulletins\u2013Obstetrics","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jad.2020.03.014_bib0016","first-page":"e571","article-title":"Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy","volume":"579","author":"Calderon-Margalit","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jad.2020.03.014_bib0017","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0021-75572009000200008","article-title":"Self-medication in nursing mothers and its influence on the duration of breastfeeding","volume":"85","author":"Chaves","year":"2009","journal-title":"J. Pediatr. (Rio J)"},{"key":"10.1016\/j.jad.2020.03.014_bib0018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.smrv.2017.10.003","article-title":"Prevalence of restless legs syndrome during pregnancy: a systematic review and meta-analysis","volume":"40","author":"Chen","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.jad.2020.03.014_bib0019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","author":"Cohen","year":"1960","journal-title":"Educ. Psychol. Meas."},{"key":"10.1016\/j.jad.2020.03.014_bib0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajog.2007.01.033","article-title":"Increasing use of antidepressants in pregnancy","volume":"196","author":"Cooper","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jad.2020.03.014_bib0021","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/pds.2184","article-title":"Prescription drug use during pregnancy in developed countries: a systematic review","volume":"20","author":"Daw","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2020.03.014_bib0022","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clinthera.2011.11.025","article-title":"Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006)","volume":"34","author":"Daw","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2020.03.014_bib0023","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/13651500903447810","article-title":"Usage of benzodiazepines: a review","volume":"14","author":"Donoghue","year":"2010","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2020.03.014_bib0024","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.03.014_bib0025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00787-014-0558-3","article-title":"Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review","volume":"23","author":"El Marroun","year":"2014","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2020.03.014_bib0026","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1701-2163(16)34772-7","article-title":"The fetal safety of benzodiazepines: an updated meta-analysis","volume":"33","author":"Enato","year":"2011","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.jad.2020.03.014_bib0027","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.genhosppsych.2018.05.010","article-title":"Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: results from a prospective registry of women with psychiatric disorders","volume":"53","author":"Freeman","year":"2018","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2020.03.014_bib0028","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phrs.2015.12.030","article-title":"Activation-induced regulation of GABAA receptors: is there a link with the molecular basis of benzodiazepine tolerance?","volume":"109","author":"Gravielle","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jad.2020.03.014_bib0029","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jclinepi.2017.10.013","article-title":"Self-reported medication use validated through record linkage to national prescribing data","volume":"94","author":"Hafferty","year":"2018","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2020.03.014_bib0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2393-14-242","article-title":"Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance","volume":"14","author":"Hanley","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jad.2020.03.014_bib0031","first-page":"17","article-title":"Categorizing the safety of medications during pregnancy and lactation","volume":"47","author":"Howland","year":"2009","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"10.1016\/j.jad.2020.03.014_bib0032","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/fcp.12209","article-title":"Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in Efemeris database","volume":"30","author":"Hurault-Delarue","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2020.03.014_bib0033","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1176\/appi.ps.53.1.39","article-title":"Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant","volume":"53","author":"Iqbal","year":"2002","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2020.03.014_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063034","article-title":"Prevalence of antidepressant use during pregnancy in denmark, a nation-wide cohort study","author":"Jimenez-Solem","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2020.03.014_bib0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2165\/00003495-198223050-00002","article-title":"Use of benzodiazepines during pregnancy, labor and lactation, with particular reference to pharmacokinetic considerations","volume":"23","author":"Kanto","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.jad.2020.03.014_bib0036","article-title":"De aankoop van geneesmiddelen via internet. EEN onderzoek naar het koopgedrag, de motieven, risicoperceptie en informatiebehoefte van online kopers van geneesmiddelen.","author":"Koenraadt","year":"2016","journal-title":"Institute"},{"key":"10.1016\/j.jad.2020.03.014_bib0037","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1039856218810162","article-title":"Perceptions of pregnant women regarding antidepressant and anxiolytic medication use during pregnancy","volume":"27","author":"Kothari","year":"2019","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.jad.2020.03.014_bib0038","first-page":"14","article-title":"Parity and sleep patterns during and after pregnancy","volume":"95","author":"Lee","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jad.2020.03.014_bib0039","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/FTD.0b013e318288453f","article-title":"Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy","volume":"35","author":"Lendoiro","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jad.2020.03.014_bib0040","first-page":"163","article-title":"The effects of benzodiazepines in pregnancy","volume":"110","author":"Leppee","year":"2010","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jad.2020.03.014_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The Prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jad.2020.03.014_bib0042","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00315304","article-title":"Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Collaborative group on drug use in pregnancy (CGDUP)","volume":"45","author":"Marchetti","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2020.03.014_bib0043","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/ADT.0000000000000044","article-title":"Trends in drug-exposed deliveries from 2002 to 2009","volume":"14","author":"Martin","year":"2015","journal-title":"Addict. Disord. Treat."},{"key":"10.1016\/j.jad.2020.03.014_bib0044","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0890-6238(94)90029-9","article-title":"The effects of benzodiazepine use during pregnancy and lactation","volume":"8","author":"McElhatton","year":"1994","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jad.2020.03.014_bib0045","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/FTD.0000000000000181","article-title":"Patterns of drugs and drug metabolites observed in meconium: what do they mean?","volume":"37","author":"McMillin","year":"2015","journal-title":"Ther. Drug Monit."},{"issue":"Suppl","key":"10.1016\/j.jad.2020.03.014_bib0046","first-page":"4","article-title":"Clinical distinctions between long-acting and short-acting benzodiazepines","volume":"53","author":"Mendelson","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.03.014_bib0047","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1552-6909.2000.tb02072.x","article-title":"Sleep disturbances during pregnancy","volume":"29","author":"Mindell","year":"2000","journal-title":"J. Obstet. Gynecol. Neonatal. Nurs."},{"key":"10.1016\/j.jad.2020.03.014_bib0048","first-page":"e51","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"51","author":"Mitchell","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jad.2020.03.014_bib0049","article-title":"Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands","author":"Molenaar","year":"2019","journal-title":"Arch. Womens Ment. Health."},{"key":"10.1016\/j.jad.2020.03.014_bib0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int. J. Evid. Based Healthc."},{"key":"10.1016\/j.jad.2020.03.014_bib0051","first-page":"69","article-title":"Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology","volume":"6","author":"Nelson","year":"1999","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2020.03.014_bib0052","doi-asserted-by":"crossref","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","author":"Nyaga","year":"2014","journal-title":"Arch. Public Health"},{"key":"10.1016\/j.jad.2020.03.014_bib0053","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000353198","article-title":"Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis","volume":"82","author":"Offidani","year":"2013","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2020.03.014_bib0054","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s10995-018-2543-9","article-title":"Cigarette smoking status and substance use in pregnancy","volume":"22","author":"Oga","year":"2018","journal-title":"Matern. Child Health J."},{"key":"10.1016\/j.jad.2020.03.014_bib0055","doi-asserted-by":"crossref","first-page":"e12309","DOI":"10.1111\/appy.12309","article-title":"Maternal exposure to benzodiazepine and risk of preterm birth and low birth weight: a case-control study using a claims database in Japan","volume":"10","author":"Ogawa","year":"2018","journal-title":"Asia Pac. Psychiatry"},{"key":"10.1016\/j.jad.2020.03.014_bib0056","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ajog.2014.10.1106","article-title":"A review of sleep-promoting medications used in pregnancy","volume":"212","author":"Okun","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jad.2020.03.014_bib0057","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2020.03.014_bib0058","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00228-009-0644-5","article-title":"Prescription drugs among pregnant women in Lome, Togo, West Africa","volume":"65","author":"Potchoo","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2020.03.014_bib0059","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ntt.2017.02.005","article-title":"Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: a population-based cohort study","volume":"61","author":"Radojcic","year":"2017","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.jad.2020.03.014_bib0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ntt.2017.02.005","article-title":"Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: a population-based cohort study","volume":"61","author":"Radoj\u010di\u0107","year":"2017","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.jad.2020.03.014_bib0061","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12664-010-0067-3","article-title":"Prevalence and risk factors for gastroesophageal reflux in pregnancy","volume":"30","author":"Ramu","year":"2011","journal-title":"Indian J. Gastroenterol."},{"key":"10.1016\/j.jad.2020.03.014_bib0062","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/aogs.12528","article-title":"Prevalence of substance abuse in pregnancy among Danish women","volume":"94","author":"Rausgaard","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jad.2020.03.014_bib0063","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00228-014-1744-4","article-title":"Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study","volume":"70","author":"Riska","year":"2014","journal-title":"Eur. J. Clin. Pharmacol"},{"key":"10.1016\/j.jad.2020.03.014_bib0064","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/01443610500508121","article-title":"Screening of substance misuse during early pregnancy in Blyth: an anonymous unlinked study","volume":"26","author":"Sanaullah","year":"2006","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.jad.2020.03.014_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/bdra.22888","article-title":"Agreement between self-report and prescription data in medical records for pregnant women","volume":"94","author":"Sarangarm","year":"2012","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.jad.2020.03.014_bib0066","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.smrv.2017.06.005","article-title":"Sleep quality during pregnancy: a meta-analysis","volume":"38","author":"Sedov","year":"2018","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jad.2020.03.014_bib0067","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2019.0963","article-title":"Association between incident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion","author":"Sheehy","year":"2019","journal-title":"JAMA Psychiatry."},{"key":"10.1016\/j.jad.2020.03.014_bib0068","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s004310051126","article-title":"Substance misuse in early pregnancy and relationship to fetal outcome","volume":"158","author":"Sherwood","year":"1999","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jad.2020.03.014_bib0069","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/GRF.0000000000000417","article-title":"Benzodiazepines in pregnancy","volume":"62","author":"Shyken","year":"2019","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.jad.2020.03.014_bib0070","first-page":"245","article-title":"Substance abuse during pregnancy in a rural population","volume":"79","author":"Sloan","year":"1992","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jad.2020.03.014_bib0071","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128312","article-title":"Trends and determinants of prescription drug use during pregnancy and postpartum in British Columbia, 2002-2011: a population-based cohort study","volume":"10","author":"Smolina","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2020.03.014_bib0072","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ije\/dyu038","article-title":"The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013","volume":"43","author":"Steel","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jad.2020.03.014_bib0073","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00787-014-0631-y","article-title":"Recent international trends in psychotropic medication prescriptions for children and adolescents","volume":"24","author":"Steinhausen","year":"2015","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2020.03.014_bib0074","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2020.03.014_bib0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jad.2009.03.005","article-title":"Anxiety and depression during pregnancy in women and men","volume":"119","author":"Teixeira","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.03.014_bib0076","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/clpt.2010.97","article-title":"Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy","volume":"88","author":"Wang","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2020.03.014_bib0077","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamapsychiatry.2017.2733","article-title":"Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes","volume":"74","author":"Yonkers","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2020.03.014_bib0078","doi-asserted-by":"crossref","DOI":"10.1186\/1753-2000-2-26","article-title":"A three-country comparison of psychotropic medication prevalence in youth","author":"Zito","year":"2008","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"key":"10.1016\/j.jad.2020.03.014_bib0079","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/pds.1254","article-title":"Antidepressant prevalence for youths: a multi-national comparison","volume":"15","author":"Zito","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719335050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719335050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:35:45Z","timestamp":1759023345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719335050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":79,"alternative-id":["S0165032719335050"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.03.014","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}